What does Caplacizumab (Cablivi) do in plain English—and how does it work inside your body?
Caplacizumab is an FDA-regulated FDA Prescription Therapeutic Agent (RxNorm RxCUI 2110616). Mechanistically, 12.1 Mechanism of Action Caplacizumab-yhdp targets the A1-domain of vWF, and inhibits the interaction between vWF and platelets, thereby reducing both vWF-mediated platelet adhesion and platelet consumption. [1][2].
When your doctor writes a prescription for Caplacizumab (RxNorm RxCUI 2110616, also dispensed under brand names including Cablivi), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Caplacizumab-yhdp targets the A1-domain of vWF, and inhibits the interaction between vWF and platelets, thereby reducing both vWF-mediated platelet adhesion and platelet consumption. [2].
Across real-world patient logs on dotMD (90% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Caplacizumab tablet bottle and confirm with your pharmacist that it matches your prescribed strength (Kit, 11 mg).